We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -6.06% | 3.10 | 3.00 | 3.20 | 3.30 | 3.05 | 3.30 | 872,250 | 15:36:39 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.18 | 2.8M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/6/2023 13:16 | Big buyer knows funds are ok for a year and more than likely knows there’s some good new pre agm. | 412069 | |
20/6/2023 11:54 | I think we have funds well in to 2024 plus THX money and the lab income. GLA | wulber | |
20/6/2023 11:18 | THE VALIRX PLACING SWEEP Roll up roll up. Let’s have a comp to see what price the placing will be done at. We know it’s coming so we may as well have a bit of fun I’m in at 4p Porky think you mentioned 5p Any other prices . | francoismyname | |
20/6/2023 10:30 | Lol sooty :) | ben gibbons | |
20/6/2023 10:20 | Trouble is Ben we have a board full of monkeys | sooty snipes | |
20/6/2023 10:11 | Not interested in what some plum on LSE says. I am interested in what the ceo of the company says. That post is from a conversation I had with Suzy this morning regarding Satu and oncobone. Besides Satu resigned from oncobone in April 2023. To much noise being made here and on LSE. Listen to the organ grinder not the monkeys! | ben gibbons | |
20/6/2023 09:27 | Read ironmighty post 09:23 on lse for confirmation mr ben 😂 | jasonpugh | |
20/6/2023 08:49 | Just for clarification.see https://oncobone.com | ben gibbons | |
20/6/2023 06:33 | Comms with George Morris last night. Obviously take with pinch of salt but if true or elements in it are true then valirx in serious trouble with fca. I sent george the rns from yesterday. His response. George “they have not communicated at all” Me. “Thoughts on rns?” George “ will look when i get a moment been on the road all day” George. “ that was an unapproved rns with no verification or counterpart sight or agreement. Technically illegal “ Me. “What does satu think?” George. “Furious along with most of oncobone” DYOR 🧐. According to satu on her LinkedIn profile she still works for oncobone. But companies house says different. Anyway she has friends at oncobone. Georges comments requires verification on all points. | jasonpugh | |
19/6/2023 19:22 | Jason. I agree Stella has an attitude but she hasn't been there long enough to hold responsible for the rest of the board. It was probably her that pulled off the deal with Imagen. I think it would be a mistake to vote her off simply because she hasn't bought any shares. To be critical she's right when she says the company lack stability. I think if we could get Adam on board with Stella, Cathy, Zai and Suzy in a scientific role we would be up and running. If we got shut of the board Adam would have to step forward if he wanted to protect his investment. | sooty snipes | |
19/6/2023 16:08 | Fundamentally the three financial stooges need replacing as they have produced zero. Panu needs to go. She creates great doubt to others and her continued non participation in buying shares is alarming. Appoint adam to the board as this would instantly double share price and create positive momentum after (no brainer). However there is something sinister about the board not wanting this. It will become apparent very soon. The inevitable consequence of being stubborn board members are your removal. The scientists remain. The finance people replaced. Forced via vote. Bolshevik 1917 comes to mind. Show me the palms of your hands board. Because shareholders want panu to buy her reaction is non compliance. Even if warren buffett advised her to buy now her original prejudice “no shareholders are going to tell me what to do!” Remains. Consequences. Removal from board and tarnished cv. DYOR | jasonpugh | |
19/6/2023 15:38 | Sooty, it's not what he says but it's the volume. We can all agree or disagree in full or part, but too much copy and paste continuously here and LSE.Porky, we get your point BTW, now leave it please.I visit the BB's to see what new gems of inspiration we have but this is too much and a unhealthy relationship you have. | wulber | |
19/6/2023 15:12 | Porky I don't agree with some of what you have to say but you have the right to say whatever you like. Don't let these oppressors of free speech say otherwise | sooty snipes | |
19/6/2023 14:40 | Porky, please stop the repetition! | wulber | |
19/6/2023 10:33 | you are talking about the old valirix... keep spreading fear! you want it to fail, just admit it. Buy | qnq | |
19/6/2023 10:21 | The longer they leave the raise the lower the price will be. People not buying the jam tomorrow mantra as been trotted out for 12 years now over hundreds of RNS’s. We all know it’s coming. Just get it over and done with. Might as well kitchen sink it and say the THX deal is a dead duck at the same time | francoismyname | |
19/6/2023 09:54 | porky writing at 2am! must be something, he knows some good news coming. another positive news this morning, Suzie focising on cash generation and not burn. people should not confuse the old valirix with the valirix shes running. read couple of comments by the two main slaggers (I think I know who they are!) about how the lab idea cant generate money! thats total rubbish. there are companies and its only a handful of them globally that are running trials for pharmas and biitechs. they qre worth in the hundreds of millions. Buy | qnq | |
19/6/2023 08:17 | @JasonPugh £7k of assets according to records at Companies House, not sure why it was RNS worthy unless as it’s a contract they thought it worth issuing an RNS to create noise to deflect from the Japan failure? Market always makes its own opinion anyhow. Two weeks until AGM then at least we know what the forward board will look like and if it’s 40m or 50m headroom - I cant see the 10m of options getting across the line can you? | porky9 | |
19/6/2023 08:04 | Lots of RNS releases at the moment, I wonder why, unfortunately they are not tangible, the market will simply not react, a continuing sh1t show! | pinkpudycat | |
19/6/2023 07:27 | Jason, this a business relationship not a break up and make up, lol. | wulber | |
19/6/2023 07:20 | The rns this morning. Look who is chairman of oncobone ventures ltd. SATU 🧐. According to LinkedIn satu is friends with cathy. Maybe suzy and satu are friends again? | jasonpugh | |
19/6/2023 07:07 | Ooh P9 - day to day positive developments here at VAL as you continue be obsessive are delusional!RNS:Inaph | wulber |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions